| Particulars |
| Company Name |
Alivus Life Sciences Ltd |
| Face Value |
2 |
| BSE Code |
543322 |
| Year End |
202403 |
| Full Year |
| Equity (Rs in Cr.) |
24.51 |
| B.V. Rs |
207.20 |
| Sales Rs in Cr. |
2,283.21 |
| NP Rs in Cr. |
471.41 |
| NP Var% |
1.00 |
| Div% |
1,125.00 |
| CPS Rs |
42.80 |
| EPS Rs |
38.50 |
| Traded Value(Rs in Lakhs) |
18.79 |
| 52 Week High |
1,335.00 |
| 52 Week Low |
755.00 |
| Price BSE |
1,089.00 |
| Price NSE |
1,089.00 |
| Market Capital(Rs in Cr.) |
13,342.45 |
| P/C Ratio |
25.40 |
| P/E Ratio |
28.30 |
| Price Vs.BV |
5.26 |
| Latest Quarter |
| Year End |
202412 |
| Sales Rs in Cr. |
641.84 |
| NP Rs in Cr. |
136.96 |
| NP Var % |
15.00 |
| Trailing Twelve Months |
| Year End |
202412 |
| Sales |
2,204.90 |
| OPM |
27.57 |
| NP |
423.50 |
| NP Var% |
-14.95 |
| EPS |
36.05 |
| PE |
30.20 |
|